CUE Archived Articles
Cue Biopharma, Inc. (CUE): Pioneering Selective T Cell Modulation in Oncology and Autoimmune Diseases
Published on March 13, 2025
Cue Biopharma (CUE): Pioneering Targeted Immune Modulation for Cancer and Autoimmune Diseases
Published on November 02, 2024
Cue Biopharma, Inc. (NASDAQ:CUE) - Selective Immune Modulation Holds Promise in Oncology and Autoimmune Disease
Published on September 24, 2024